Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis
Latest Information Update: 25 Jul 2023
Price :
$35 *
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Perennial allergic rhinitis
- Focus Adverse reactions
- Sponsors GSK
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Jun 2012 New trial record